← Back to all recalls
FDA RECALL ALERT
Aisling Doxorubicin Hydrochloride Liposome Injection
Sun Pharma is recalling Aisling Doxorubicin Hydrochloride Liposome Injection 50mg/25 mL nationwide due to potential glass particle contamination.
What to do
Stop using the product immediately and contact Inmar Inc. at 855-745-9357 or rxrecalls@inmar.com for recall instructions.
Why it was recalled
Sun Pharma is recalling Aisling Doxorubicin Hydrochloride Liposome Injection 50mg/25 mL distributed nationwide due to the potential presence of glass particles in the product.
Is mine affected?
This recall covers the product below. If you have it, yours is affected.
Aisling Doxorubicin Hydrochloride Liposome Injection, 50mg 25 mL
Official source
Editorial summary by Recall Canary · last updated 2026-05-13 · primary source: U.S. Food and Drug Administration